These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 7617858)

  • 1. Clinical safety of gadopentetate dimeglumine.
    Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
    Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 3. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ; Prince MR; Chenevert TL
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
    Haustein J; Laniado M; Niendorf HP; Louton T; Beck W; Planitzer J; Schöffel M; Reiser M; Kaiser W; Schörner W
    Radiology; 1993 Mar; 186(3):855-60. PubMed ID: 8430199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
    Jinkins JR; Rauch RA; Gee GT; Bazan C; Xiong L; Kashanian FK; Hanna EP
    Radiology; 1995 Oct; 197(1):247-51. PubMed ID: 7568831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.
    Mühler A; Saeed M; Brasch RC; Higgins CB
    Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye and testicular pain after administration of gadopentetate dimeglumine.
    Padhani AR; Lopez AJ; Revell PB; MacVicar DA
    AJR Am J Roentgenol; 1995 Aug; 165(2):484-5. PubMed ID: 7618587
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gadolinium-DTPA dimeglumine administered orally for the study of the abdomen with magnetic resonance. Clinical evaluation and tolerance].
    Squillaci E; Crecco M; Cecconi L; Lupoi D; Sergiacomi GL; Simonetti G
    Radiol Med; 1993 Sep; 86(3):284-93. PubMed ID: 8210538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe adverse reaction to iv gadopentetate dimeglumine.
    Takebayashi S; Sugiyama M; Nagase M; Matsubara S
    AJR Am J Roentgenol; 1993 Mar; 160(3):659. PubMed ID: 8430574
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections.
    Abujudeh HH; Kosaraju VK; Kaewlai R
    AJR Am J Roentgenol; 2010 Feb; 194(2):430-4. PubMed ID: 20093606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
    Alhassan A; Weinmann HJ
    AJNR Am J Neuroradiol; 1997 Apr; 18(4):785-6; author reply 786-8. PubMed ID: 9127052
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
    García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
    Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
    [No Abstract]   [Full Text] [Related]  

  • 17. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S; Hoffman JC
    AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.